Elan Corporation PLC (ELN)
OPEN
LAST
$
PREV CLOSE
CHANGE
VOLUME
Overview
News
People
Financials
Employees
Number of Employees: 1610
Revenue per Employee: $358,535
Corporate Structure
CHIEF EXECUTIVE OFFICER
G. Kelly Martin
TOP EXECUTIVES
Gary Kennedy Non-Executive Director
William R. Rohn Non-Executive Director
Shane Cooke Executive Director, Chief Financial Officer and Head of Elan Drug Technologies
William F. Daniel Executive Vice President and Company Secretary
Dr.Lars Ekman, M.D., Ph.D. Non-Executive Director
Dr.Floyd E. Bloom Non-Executive Director
Kieran McGowan Lead Independent Director
Ann Maynard Gray Non-Executive Director
Kyran McLaughlin Non-Executive Chairman of the Board
Dr. Ivan Lieberburg, MD, PhD Executive Vice President and Chief Medical Officer
Dr. Dennis J. Selkoe, MD Non-Executive Director
Nigel Clerkin Senior Vice President, Finance and Group Controller
Richard Collier Executive Vice President and General Counsel
Dr. Allison Hulme, PhD Executive Vice President, Global Development
Karen S. Kim Executive Vice President of Corporate Strategy & Alliances, Communications, Branding and Specialty B
Kathleen Martorano Executive Vice President, Strategic Human Resources
Dr. Dale Schenk, PhD Executive Vice President and Chief Scientific Officer
Dr.Ted Yednock, PhD Executive Vice President and Head of Global Research
Dr. David W. Feigal, Jr, MD Senior Vice President, Head of Global Regulatory and Global Safety Surveillance
Dr. Menghis Bairu, MD Senior Vice President and Head of International
Jeffrey Shames Non-Executive Director
Giles Kerr Non-Executive Director
Jonas Frick Non-Executive Director
Dr. Johannes Roebers, PhD Senior Vice President and Head of Biologic Strategy, Planning and Operations
Dr. James Callaway, PhD Senior Vice President and Head of Immunotherapy AD Clinical Programs
